Advertisement

Topics

Opexa Therapeutics, Inc.: Acer Therapeutics and Opexa Therapeutics Sign Merger Agreement

06:09 EDT 3 Jul 2017 | FinanzNachrichten

Merger to create a pre-NDA-stage, NASDAQ-listed, pharmaceutical company focused on the development and commercialization of therapies for serious rare diseases with critical unmet medical need Conc...

Original Article: Opexa Therapeutics, Inc.: Acer Therapeutics and Opexa Therapeutics Sign Merger Agreement

NEXT ARTICLE

More From BioPortfolio on "Opexa Therapeutics, Inc.: Acer Therapeutics and Opexa Therapeutics Sign Merger Agreement"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...